Advocacy and Assess: Coordinated National Strategy

• Establish 3–5 national advocacy priorities to guide coordinated efforts and advance progress on key policy, regulatory, and access challenges.
• Develop standardized clinician engagement pathways for CDA clinician group input submissions and expert review participation.
• Identify approaches to improve therapy access by addressing SAP, clinical trial, and policy barriers.

Network Sustainability & Strategic Planning

• Identify 3–5 key network priorities
• Develop a draft sustainability roadmap including funding diversification and strategic partnerships

Building on Success: Sustaining and Strengthening Pre-Clinical Initiatives

• Reflect on the successes, challenges, and impact of current pre-clinical initiatives.
• Explore opportunities to increase pre-clinical recognition, visibility, and engagement.
• Identify priority activities for continuation and develop strategies for long-term sustainability.
• Develop a roadmap of pre-clinical priorities for trainees, early-, mid- and senior-career investigators, gaps, and next steps to maintain momentum and guide future programming.

Additional topics coming soon – Stay tuned!